News Swallowing problems are common for MS patients, review study finds Swallowing problems are common for MS patients, review study finds Swallowing difficulties could lead to life-threatening complications by Lindsey Shapiro, PhD | February 7, 2023 Share this article: Share article via email Copy article link Nearly half of multiple sclerosis (MS) patients experience swallowing difficulties, which is notably higher than rates seen in the general population, according to a recent review study and meta-analysis. Because swallowing problems, or dysphagia, can lead to serious, sometimes life-threatening, complications, it is important for patients to be routinely monitored for this symptom and potential complications. The study overall offers “insight into the importance of routine and systemic checkups in MS patients in an effort to prevent the progression of severe comorbidities [co-existing conditions],” researchers wrote. The review study, “Prevalence of dysphagia in patients with multiple sclerosis: A systematic review and meta-analysis,” was published in the Journal of Clinical Neuroscience. Recommended Reading February 2, 2023 News by Lindsey Shapiro, PhD Coconut Oil and Green Tea Lead to Gait, Balance Gains in MS Patients Dysphagia can lead to weight loss, dehydration, and other complications MS lesions can impact the function of muscles required for proper swallowing, contributing to relatively high rates of dysphagia among MS patients. These swallowing problems can lead to weight loss, dehydration, and bad breath, in addition to life-threatening complications such as choking or aspiration pneumonia ā an infection caused by food being inhaled into the respiratory tract instead of properly swallowed. Dysphagia can also have a significant negative impact on quality of life and contribute to mental health problems surrounding eating and drinking. Still, the exact prevalence of dysphagia, and potential risk factors contributing to this symptom in MS, have not been established. “Identifying dysphagia in the early stages can help reduce its consequences and apply better preventive measures to stop the progression of symptoms in those at risk,” the researchers wrote. To get a better estimate of how prevalent dysphagia is in MS, researchers in Iran conducted a systematic review of studies published up to May 2022. The analysis included 54 studies from countries worldwide, which cumulatively involved 11,266 MS patients. Ultimately, we need to focus on the management of dysphagia among MS patients in an effort to prevent its catastrophic side-effects. Nearly 50% of MS patients reported difficulties in swallowing Overall, 5,047 patients, or 44.8%, were reported to have dysphagia. Still, rates varied substantially between studies, ranging from 9% to 100%. The researchers noted that different studies evaluated the presence of dysphagia in different ways. For example, while some studies used an instrument to measure swallowing, like an endoscope, others used screening questionnaires or other types of clinical exams. To account for potential effects of different measurement strategies, rates of dysphagia were examined in four subgroups, divided by their diagnostic method: instrumental, screening questionnaire, clinical examination, or other. Instrumental approaches had the highest rates of dysphagia (65.7%), followed by screening (43.2%), clinical exam (34.8%), and other (29%). Overall, the findings indicate that the prevalence of dysphagia in MS patients is “significantly higher” than in the general population, the researchers wrote. “Ultimately, we need to focus on the management of dysphagia among MS patients in an effort to prevent its catastrophic side-effects,” the team added. “More research is required to enlighten the ambiguity surrounding dysphagia management.” Still, the analysis lacked information about different types of dysphagia and the treatments patients may have been receiving. These are areas that require additional research, the team noted. Print This Page About the Author Lindsey Shapiro, PhD Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimerās disease. Tags complications, dysphagia, MS patients
December 9, 2021 News by Patricia Inacio, PhD FDA Approves Lyvispah, Granular Form of Baclofen, to Treat Spasticity
February 20, 2020 Columns by Jennifer (Jenn) Powell Finding My Way Through Sickness and Sadness with SPMS
February 14, 2020 News by Iqra Mumal, MSc Urinary Diversion Surgery May Be Used as Last Resort for Treating Urological Dysfunction in MS Patients, Study Shows